Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research focused on Oxaliplatin and Apatinib, with related work in Cancer research, Capecitabine, Neutropenia. Notable publications include 'A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma', 'A phase II, multicenter, placebo-controlled trial of apatinib in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) after two previous treatment regimens', and 'Insights into the involvement of noncoding RNAs in 5-fluorouracil drug resistance'.
Clinical trials of nanoparticle-enhanced CAR-T and NK cell therapies in oncology: overcoming translational and clinical challenges - a mini review
Molecular Engineering of NIR-II Excitable Phototheranostic for Mitochondria-Targeted Cancer Photoimmunotherapy
METTL3/YTHDC1 mediates up-regulation of lncRNA OGRU in an m6A-dependent manner involving in oxidative stress and inflammation of HG-induced Müller cells
Müller Cells Harboring Exosomal lncRNA OGRU Modulate Microglia Polarization in Diabetic Retinopathy by Serving as miRNA Sponges
Insights into the involvement of noncoding RNAs in 5-fluorouracil drug resistance
Lung-protective Ventilation in Patients with Brain Injury
Efficacy and safety of rhLTα-Da with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-labelled, controlled, phase IIb trial.
A phase II, multicenter, open-label, single-arm trial of famitinib in patients with advanced recurrent and/or metastatic nasopharyngeal carcinoma (NPC) after two previous treatment regimens.
A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma
A phase II, multicenter, placebo-controlled trial of apatinib in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) after two previous treatment regimens.
A Phase II Study of Capecitabine plus Oxaliplatin as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer